1-3 of 3
Giuseppe Rossi
Close
Sort by
Journal Articles

MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective study

Chiara Pagani, Chiara Rusconi, Alessia Dalla Pria, Emanuele Ravano, Philipp Schommers, Mariana Bastos-Oreiro, Luisa Verga, Guido Gini, Michele Spina, Luca Arcaini, Sara Steffanoni, Davide Dalu, Lara Crucitti, Luisa Lorenzi, Piera Balzarini, Chiara Cattaneo, Lucia Bongiovanni, Andreas Rosenwald, Fabio Facchetti, Mark Bower, Andrés J. M. Ferreri, Giuseppe Rossi, Alessandra Tucci, Alessandro Re
Journal: Blood Advances
Blood Adv (2024) 8 (4): 968–977.
https://doi.org/10.1182/bloodadvances.2023010704
Published: 2024
Journal Articles

Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma

Andrés J. M. Ferreri, Piera Angelillo, Federico Erbella, Chiara Cattaneo, Luisa Verga, Arben Lleshi, Bernardino Allione, Maurilio Ponzoni, Fabio Facchetti, Chiara Pagani, Marco Foppoli, Lorenza Pecciarini, Marianna Sassone, Sara Steffanoni, Elena Flospergher, Giuseppe Rossi, Michele Spina, Alessandro Re
Journal: Blood Advances
Blood Adv (2022) 6 (22): 5811–5820.
https://doi.org/10.1182/bloodadvances.2022007475
Published: 2022
Journal Articles

Role of stem cell transplant in CD30 + PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2

Clinical Trials & Observations
Kerry J. Savage, Steven M. Horwitz, Ranjana Advani, Jacob Haaber Christensen, Eva Domingo-Domenech, Giuseppe Rossi, Franck Morschhauser, Onder Alpdogan, Cheolwon Suh, Kensei Tobinai, Andrei Shustov, Marek Trneny, Sam Yuen, Pier Luigi Zinzani, Lorenz Trümper, Tim Ilidge, Owen A. O’Connor, Barbara Pro, Harry Miao, Veronica Bunn, Keenan Fenton, Michelle Fanale, Markus Puhlmann, Swaminathan Iyer
Journal: Blood Advances
Blood Adv (2022) 6 (19): 5550–5555.
https://doi.org/10.1182/bloodadvances.2020003971
Published: 2022
Includes: Supplemental data